Predict your next investment

Other

See what CB Insights has to offer

Investments

52

Portfolio Exits

22

About ProMed Capital

ProMed Capital is an investment organization investing in Israeli medical device start ups.

ProMed Capital Headquarters Location

Israel

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest ProMed Capital News

Experity Ventures, LLC Closes On $100 Million Structured Credit Facility

Aug 3, 2020

Experity Ventures, LLC Closes On $100 Million Structured Credit Facility Financing will support growth plan of ProMed, its newly acquired medical receivables business unit Author: Aug 3, 2020 5:00 PM EDT CONSHOHOCKEN, Pa., Aug. 3, 2020 /PRNewswire/ -- Experity Ventures, LLC (EV) is pleased to announce that it has closed on a structured credit facility for an initial $65 million and up to $100 million to support the growth plan for ProMed Capital. ProMed is a newly acquired portfolio company of Experity. Experity Ventures Founder and Chairman, Joseph Greco stated, "This structured facility comes on the heels of our recent acquisition of ProMed Capital and supports our plan of accelerated, organic and strategic growth for the company. We plan to be disciplined, yet opportunistic in expanding on ProMed's leadership position in an exciting and evolving space." Experity CEO, Ryan Silverman added, "We were able to conclude this transaction under very favorable terms with a partner that sees the value of our platform and is equally excited to help us realize our growth potential." About ProMed Founded in 2013, ProMed is a leading provider of medical receivable funding solutions. ProMed partners with healthcare providers, surgery centers and diagnostic and related facilities throughout the U.S. that provide patient care in exchange for medial liens (ML's) or medical letters of protection (MLOP's). The company predominately funds medical services for patients who have been injured as a result of a personal injury accident or event. Based in Las Vegas, NV, ProMed provides immediate reimbursement to doctors, surgeons, medical facilities and other professionals on behalf of patients while obtaining the healthcare provider's ML/MLOP against contingent future legal proceeds. Victims of personal injury can get access to the healthcare they need whether they have health insurance or not, and medical providers can enhance their practices and serve this patient population, while immediately improving cash flow and financial liquidity. For more information on ProMed, please visit www.promedcapital.com . About Experity Ventures Experity Ventures, founded in 2019, is the parent company for Nexify Capital and Nexify Solutions, MedSolve Financial Group, Thrivest Legal Funding, LLC / dba Thrivest Link and ProMed Capital. Nexify Capital has entered into several strategic financing and operational partnerships with legal funding companies in the United States. Nexify Solutions develops and markets best in class enterprise and workflow software for the legal funding marketplace, which is designed to automate pre-settlement funding from intake to decision analytics, to servicing and payoff, while offering full accounting and reporting capabilities. Thrivest is a direct to market pre-settlement legal funding company that has successfully provided thousands of non-recourse advances to individuals with pending litigation, predominately in personal injury cases. Experity has offices in Philadelphia, New York, Nevada and Florida. For more information on Experity, please visit www.experityventures.com or contact Ryan Silverman at rsilverman@experityventures.com , (267)-538-1517. View original content: http://www.prnewswire.com/news-releases/experity-ventures-llc-closes-on-100-million-structured-credit-facility-301104985.html

ProMed Capital Investments

52 Investments

ProMed Capital has made 52 investments. Their latest investment was in HDH Medical as part of their Seed on March 3, 2007.

CBI Logo

ProMed Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/8/2007

Seed

HDH Medical

$1.5M

Yes

1

1/5/2007

Unattributed VC - V

Matritech

$4.37M

No

12/25/2006

PIPE - III

Novadel Pharma

$14.24M

Yes

9/22/2006

Private Equity - III

Subscribe to see more

$99M

Subscribe to see more

0

7/24/2006

PIPE

Subscribe to see more

$99M

Subscribe to see more

0

Date

3/8/2007

1/5/2007

12/25/2006

9/22/2006

7/24/2006

Round

Seed

Unattributed VC - V

PIPE - III

Private Equity - III

PIPE

Company

HDH Medical

Matritech

Novadel Pharma

Subscribe to see more

Subscribe to see more

Amount

$1.5M

$4.37M

$14.24M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

0

0

ProMed Capital Portfolio Exits

22 Portfolio Exits

ProMed Capital has 22 portfolio exits. Their latest portfolio exit was Auxilium Pharmaceuticals on October 09, 2014.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

10/9/2014

Acq - P2P

$99M

2

5/16/2014

Acq - P2P

$99M

1

8/6/2010

Acquired

$99M

4/19/2010

Merger

Subscribe to see more

$99M

Subscribe to see more

10

8/18/2008

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

10/9/2014

5/16/2014

8/6/2010

4/19/2010

8/18/2008

Exit

Acq - P2P

Acq - P2P

Acquired

Merger

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

2

1

10

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.